Introduction
Rheb was first described in 1994 by differential cloning of neuronal activity-dependent genes in adult rat hippocampus; Rheb mRNA was found to be rapidly induced in hippocampal granule cells by seizures and by N-methyl-D-aspartate receptor-dependent synaptic activity (Yamagata et al., 1994) . Rheb was subsequently found to be widely, if not ubiquitously, expressed in human tissues, with highest levels found in skeletal and cardiac muscle, testes, and ovary (Gromov et al., 1995; Clark et al., 1997; Mizuki et al., 1996) . Within the extended group of Ras-related proteins, it is most closely related to the Ras, Rap, Ral subfamily with 35.8% sequence identity to H-Ras and 525% identity with the Rho, Rab, and ARF subfamilies (Yamagata et al., 1994; Mach et al., 2000) . Moreover, it shares with Ras and Rap six of the nine amino acids in the Ras core effector domain with two of the non-identical amino acids being conservative substitutions (Yamagata et al., 1994; Yee and Worley, 1997) . However, almost all Ras family members have a conserved glycine at position 12 in the G1 domain, but the corresponding residue in mammalian Rheb (position 15) is arginine; any change in this position in Ras results in activation which suggests that wild type Rheb could be constitutively active (Barbacid, 1987; Yamagata et al., 1994) . There, however, have been no measurements in cells of Rheb activation, i.e., the per cent of Rheb molecules in the active GTP-bound state.
Because of the high similarity of Ras and Rheb in the effector domain, it was postulated that Rheb could interact with Ras effectors and, indeed, two groups have shown that purified Rheb binds Raf-1 kinase in vitro (Yee and Worley, 1997; Clark et al., 1997) . The Rheb-Raf-1 interaction appeared to be physiologically relevant because one of the groups showed that transfected Rheb cooperated synergistically with Raf-1 to transform NIH3T3 cells, as potently as the combination of wild type Ras and Raf-1 (Yee and Worley, 1997) . However, the other group demonstrated that Rheb antagonized transformation of NIH3T3 cells induced by an oncogenic constitutively-active Ras, and decreased transcription from a Ras-responsive promoter (Clark et al., 1997) . One way, at least in part, to reconcile these seemingly disparate results would be if Rheb inhibits B-Raf kinase. Compared with Raf-1, BRaf has a higher basal kinase activity and interacts with their shared targets MEK-1 and MEK-2 with greater affinity; as a consequence, B-Raf appears to be the major Ras effector and MEK activator in several cell types including some strains of NIH3T3 cells Eychene et al., 1995; Papin et al., 1995 Papin et al., , 1996 Papin et al., , 1998 Catling et al., 1994; Jaiswal et al., 1994; Pritchard et al., 1995; Reuter et al., 1995; Vossler et al., 1997) . MEK is the immediate upstream activator of the mitogen-activated protein (MAP) kinases, ERK-1 and ERK-2, which are required for many of the growth-promoting effects of Ras (Campbell et al., 1998) . Thus, in transfection experiments with overexpressed proteins, the combination of Rheb and Raf-1 could be transforming if Rheb activates Raf-1, while Rheb by itself could antagonize Ras functions by inhibiting B-Raf kinase.
In this study, we show that endogenous Rheb is highly activated, even under basal conditions, and that the activation state of transfected Rheb increases progressively with the amount of Rheb expressed; the latter data would appear to have important implications concerning the interpretation of data from experiments in which Ras and other small G proteins are exogenously expressed in cells. In addition, we show that Rheb and B-Raf kinase are associated in vivo, and that Rheb inhibits B-Raf kinase activity and B-Raf-dependent activation of the transcription factor Elk-1.
Results
Rheb expression in NB2A, C6, PC-12, BHK, and CHOK-1 cells Because Rheb is widely expressed in brain tissue, we examined Rheb expression in cultured cells of neuronal origin. Western blotting demonstrated that Rheb was expressed, albeit at relatively low levels, in NB2A mouse neuroblastoma cells, C6 rat glioma cells, and PC-12 rat pheochromotycoma cells (Figure 1 , lanes 3 -5, respectively; lanes 1 and 2 show Chinese hamster ovary (CHOK-1) cells transfected with empty vector or Rheb expression vector to positively identify Rheb on the blots). The blot in Figure 1 was generated using an anti-Rheb antibody directed against the C terminus, but similar results were found with an anti-N terminus Rheb antibody. Previous reports have found Rheb mRNA induction by growth factors in Balb/c3T3 fibroblasts (Yamagata et al., 1994) , and Rheb protein has been detected by Western blotting in NIH3T3 cells (Clark et al., 1997) . Thus, Rheb is expressed in fibroblasts, and we found Rheb protein in baby hamster kidney (BHK) cells (Figure 1 , lane 6), but we did not detect a definite signal for Rheb in CHOK-1 cells (Figure 1 , lane 1).
Activation levels of endogenous Rheb and of transfected Rheb
We assessed the activation state of Rheb, both of the endogenous protein in neuronal cells as well as of Rheb expressed from the pRK5-myc-Rheb vector in CHOK-1 cells. As described in Materials and methods, we used a modification of a method for measuring Ras activation (Scheele et al., 1995; Dupuy et al., 2001; Prigent et al., 1996; Sharma et al., 1998; Suhasini et al., 1998) , and this assay measures the amount of GTP and the sum of GTP plus GDP bound to Rheb. All samples are split in half, with one-half of the sample receiving an anti-Rheb or anti-myc antibody (the experimental sample), and the other half of the sample receiving non-specific immunoglobulin (control sample). Values presented are the difference between experimental and control samples with control samples generally being 510% of experimental samples. For logarithmically growing C6 cells, we found 0.5+0.04 fmol/mg DNA of GTP bound to Rheb, and 2.08+0.2 fmol/mg DNA of GTP+GDP bound to Rheb (mean+s.d. of three independent experiments performed in duplicate; corresponding values for the control samples were 0.03 and 0.15 fmol/mg DNA). These values yield a Rheb activation level of 24.3+4% ( Figure 2a , open bar). Interestingly, Rheb's activation state remained 420%, even after 24 -48 h of serum starvation, and serum stimulation of serum-starved cells caused only a small 2 -4% increase in Rheb activation. We found similar results in NB2A and, as described below, in PC-12 cells; in NB2A cells, Rheb activation was similar under all growth conditions, and was 22+4% in serum-starved, 27+5% in serumstimulated, and 26+3% in logarithmically growing cells (mean+s.d. of at least three independent experiments performed in duplicate). These Rheb activation levels, particularly for serum-starved cells, are considerably higher than we and others have found for other wild type Ras-related proteins, including Ras and Rap 1: activation levels for serum-starved cells are generally in the range of 0.5 -8%, depending on the cell type, and activation levels for logarithmically growing or serum-stimulated cells are generally between 10 -18% (Scheele et al., 1995; Tian et al., 2000; von Lintig et al., 2000; Sharma et al., 1998; Prigent et al., 1996; Haugh et al., 1999; Satoh et al., 1990a,b) . To perform experiments under identical conditions, we measured Rheb, Ras, and Rap 1 activation in serum-starved PC-12 cells, and found activation levels of 23+4%, 3+0.5%, and 5+0.7%, respectively. Thus, compared to other Ras-related proteins, Rheb appears to be constitutively in a highly activated state, and its activation state is unaffected by growth conditions (Scheele et al., 1995; Guha et al., 1996; Pilz et al., 1997) . Since we found high Rheb activation in three different neuronal cell lines, it seemed unlikely that the increased Rheb activation could be from genetic mutations in Rheb in these cells. To study Rheb activation further, we transfected variable amounts of myc-tagged wild type Rheb into CHOK-1 and BHK cells, and isolated Rheb using an anti-myc antibody. We found a progressive increase in total nucleotides (GTP+GDP) bound to Rheb when we transfected from 15 to 150 ng of the Rheb expression vector (Table 1 ; data are for CHOK-1 cells, but similar results were found for BHK cells). Although the increase in Rheb-bound GTP and GDP was not linear over the range of DNA transfected, it correlated well with the increase in the amount of Rheb protein expressed at each level of transfected DNA: Rheb protein, as assessed by Western blotting using either an anti-Rheb antibody ( Figure 2b , lanes 2 -5) or an anti-myc antibody ( Figure 2c , lanes 2 -5), showed a progressive but nonlinear increase over the range of DNA transfected. As can be noted in Table 1 , the rate of increase in Rheb-bound GTP was greater than that for Rheb-bound GTP+GDP; thus, over the range of DNA transfected, there was a continual increase in Rheb activation from 26.2 to 85.3% ( Figure 2a , closed bars; again, the data are for CHOK-1 cells, but similar results were obtained in BHK cells). These data provide further evidence that Rheb is constitutively in a highly activated state, and suggest that negative regulators of Rheb's activation, e.g., Rheb GTPase activating proteins (GAPs), are at relatively limiting intracellular concentrations.
To examine further the cause of Rheb's high activation levels, we studied two mutants of Rheb in which arginine 15 and serine 16 were changed to glycine. In Ras the corresponding residues at positions 12 and 13 are both glycines, and any mutation at position 12 is activating while some mutations at position 13 are activating (Barbacid, 1987) . Both the single R15G and the double R15G, S16G Rheb mutants transfected into logarithmically growing CHOK-1 cells exhibited similar high activation levels as wild type Rheb, i.e., 25+5% to 80+7% (mean+s.d. of three experiments performed in duplicate) over a range of 5 -100 ng of transfected DNA. Thus, the arginine and serine at positions 15 and 16 in Rheb do not appear to be responsible for Rheb's high activation state, and these data are consistent with the finding of Yamagata et al. (1994) that purified Rheb in vitro has a similar intrinsic GTPase activity as Ras. Figure 2 Rheb activation levels. C6 cells grown to subconfluence on 100 mm plates (a, open bar) and CHOK-1 cells grown on 6-well cluster dishes and transfected with the indicated amounts of the pRK5-myc-Rheb expression vector (a, closed bars) were lysed, and Rheb was isolated by immunoprecipitation using either the anti-Rheb C antibody (C6 cells) or an anti-myc antibody (CHOK-1 cells). The activation state of Rheb, i.e., the per cent of Rheb molecules in the active GTP bound state, was measured by a coupled enzymatic assay as described in Materials and methods, and the data are the means+s.d. of at least three independent experiments performed in duplicate (a). Proteins recovered from the immunoprecipitates were subjected to SDS -PAGE and Western blotting using the anti-Rheb N antibody (b) or anti-myc antibody (c). In (b) and (c), lane 1 is from C6 cells, and lanes 2 -5 are from CHOK-1 cells transfected with 15, 30, 60 and 150 ng of the pRK5-myc-Rheb expression vector CHOK-1 cells grown on 6-well cluster dishes and transfected with the indicated amounts of the pRK5-myc-Rheb expression vector were extracted and the samples were split in half, receiving either a mouse monoclonal anti-myc antibody (experimental sample) or mouse IgG (control sample). To both the control and experimental samples were added protein G agarose beads, and after a 1 h incubation, the beads were washed and heated to 1008C to elute bound nucleotides. GTP, and the sum of GTP plus GDP, were measured in coupled enzymatic assays as described in Materials and methods. The data are different between the experimental samples and the control samples with the latter ranging between 0.02 and 0.1 fmol/mg protein for GTP, and 0.1 and 0.5 fmol/mg protein for the sum of GTP+GDP. Values are the mean+s.d. of three independent experiments performed in duplicate
Rheb associates with B-Raf kinase in vivo
Previous work has shown that Rheb binds Raf-1 in vitro, and B-Raf kinase was found together with Raf-1 in a complex bound to Rheb (Yee and Worley, 1997; Clark et al., 1997) . These data suggest that Rheb may interact with B-Raf kinase in vivo, although B-Rafkinase could have been associated with other proteins found in the complex including MEK and 14-3-3 proteins (Yee and Worley, 1997) . To study a possible direct Rheb-B-Raf kinase interaction, we performed co-immunoprecipitation studies. We transfected CHOK-1 cells with EE-tagged B-Raf kinase, myctagged Rheb, or the combination of the two, and after immunoprecipitating with an anti-EE antibody or an anti-myc antibody, we analysed the precipitates by Western blotting with an anti-B-Raf kinase or antiRheb antibody (Figure 3 ). We found B-Raf kinase in the anti-myc immunoprecipitates only when we co- . These experiments were performed transfecting 100 ng of pRK5-myc-Rheb DNA, but similar results were obtained when 50 ng of Rheb DNA was used. The association of endogenous Rheb and B-Raf kinase was below the level of detection due to the fact that the efficiency of immunoprecipitation was very low with the available antibodies.
Rheb inhibits B-Raf kinase activity and MAP kinase activation
Since Rheb associates with B-Raf kinase in vivo, we examined the effect of Rheb on B-Raf kinase activity. We transfected logarithmically-growing CHOK-1 cells with expression vectors encoding B-Raf kinase, with or without 100 ng of Ras G12V or Rheb expression vectors, isolated B-Raf kinase by immunoprecipitation, and measured B-Raf kinase activity using MEK as a substrate ( Figure 4) . As described by other investigators in different cell types (Kuroda et al., 1996; Marais et al., 1997; Jelinek et al., 1996) , we found that co- 6 and 7) ). The differences in B-Raf kinase activity were not secondary to differences in the amount of B-Raf kinase present in the assay, as similar amounts of B-Raf kinase were in the immunoprecipitates under all conditions (Figure 4b ). In addition, Rheb inhibition of B-Raf kinase activity was observed under different culture conditions because Figure 4a , left panel, shows results for cells maintained in medium containing 10% fetal bovine serum (FBS), whereas the right panel shows results for cells cultured in 0.1% FBS. Thus, Rheb is a potent inhibitor of B-Raf kinase activity. Since B-Raf kinase activates the MAP kinases ERK-1 and -2 through MEK-1/2, we studied the effects of Rheb on B-Raf kinase-induced activation of ERK-1. Consistent with its inhibitory effect on B-Raf kinase activity, we found that Rheb markedly diminished BRaf kinase activation of ERK-1: when 12.5, 25, or 75 ng of pMT2-Rheb DNA were co-transfected with B-Raf kinase and HA-tagged ERK-1 expression vectors into CHOK-1 cells, there was a 44, 64, and 93%, respectively, decrease in ERK-1 activation (mean of duplicates from a representative experiment). Under identical conditions, co-transfecting pDCR-HRas(Val12) with the B-Raf kinase and HA-tagged ERK-1 expression vectors caused a more than 10-fold increase in ERK-1 activity.
Rheb inhibits B-Raf kinase-dependent transcriptional activation of Elk-1
Since Rheb inhibited B-Raf kinase activity, we decided to study the effect of Rheb on B-Raf kinase-dependent transcription. Because B-Raf kinase is an important activator of Erk-1 and Erk-2 (Vossler et al., 1997; Jaiswal et al., 1994) and the transcription factor Elk-1 is a physiological target of these two MAP kinases (Johnson et al., 1996) , we used a chimeric Elk-Gal4 construct to measure B-Raf kinase activation of a Gal-4-dependent reporter gene (Qiu et al., 2000) . We performed these studies in two of the neuronal cell lines which have endogenous Rheb, i.e., NB2A and PC-12 cells, and in two fibroblastic cell lines, one with and one without endogenous Rheb, i.e., BHK and CHOK-1 cells. To minimize the effects of growth factors on B-Raf kinase activation, these studies were performed in serum-starved cells. Because of changes in Rheb activation at different levels of Rheb expression (Figure 2a) , we performed these studies transfecting 
b). Similar results were obtained in two other independent experiments
Rheb and B-Raf kinase E Im et al both high and low amounts of Rheb DNA, i.e., 100 ng ( Figure 5a ) and 5 -25 ng of pMT2-Rheb ( Figure 5c ); at the low levels of DNA, the activation state of the transfected Rheb is similar to that of endogenous Rheb ( Figure 2a) . Expression of B-Raf kinase increased reporter gene activity 2 -3-fold in NB2A, PC-12, and BHK cells, and approximately ninefold in CHOK-1 cells (Figure 5a ,c, bars with narrow diagonal stripes). There was no significant difference in transfection efficiency or in BRaf kinase expression between BHK and CHOK-1 cells (data not shown). As expected, co-expression of an activated Ras protein caused a marked increase in reporter gene activity with about a 30 -60-fold increase in NB2A, BHK, and CHOK-1 cells, and more than a 1000-fold increase in PC-12 cells (Figure 5a ,c, bars with wide cross-hatching). Co-expression of wild type Rap 1A caused a modest decrease in reporter gene activity in NB2A and PC-12 cells, and had no effect in BHK cells (Figure 5a , bars with narrow cross-hatching). In all four cell lines, co-expression of wild type Rheb significantly inhibited B-Raf-kinase-dependent transcription with Elk-Gal4 activity suppressed below basal levels in NB2A cells (Figure 5a,c, filled bars) . The different effects of Ras, Rap 1A, and Rheb observed in these studies were not secondary to (Figure 5b ; data are shown only for NB2A cells, but similar results were found for the other cell lines). Thus, Rheb inhibits B-Raf kinase function in several different cell types, both when expressed at high and low levels. This inhibitory effect of Rheb appeared to be specific for B-Raf kinase because Rheb had no effect on Raf-1 kinase-dependent activation of the Elk-Gal 4 construct in BHK cells, while activated Ras stimulated Raf-1-dependent transcription (Figure 5d ). The inhibition of B-Raf kinasedependent transcription by Rheb may explain why similar levels of B-Raf kinase expression in four different cell types resulted in greater transcriptional activation of Elk-Gal4 in Rheb-deficient CHOK-1 cells compared to the other three cell types which contain endogenous Rheb.
Discussion
In addition to being widely expressed in rat and human tissues, Rheb homologs have been identified in the budding yeast Saccharomyces cerevisiae, the fission yeast Schizosaccharomyces pombe, the sea squirt Ciona intestinalis, the zebrafish Danio rerio, and the fruit fly Drosophila melanogaster (Mach et al., 2000; Urano et al., 2000) . The rat and human protein have 98.9% amino acid identity, while across all species Rheb exhibits 26% amino acid sequence identity and 57% similarity (Urano et al., 2000; Mizuki et al., 1996) .
Data from the yeast protein and from studies in NIH3T3 cells have provided indirect evidence that the activation state of wild type Rheb is at a relatively high level, and that it apparently cannot be increased further by a genetic mutation. Thus, in S. pombe mutation of the glutamine at position 64 in Rheb, which corresponds to position 61 in Ras and leads to constitutive Ras activation (Barbacid, 1987) , did not enhance Rheb function, and the phenotype of NIH3T3 cells transfected with wild type Rheb or Rheb Q64L was virtually indistinguishable (Clark et al., 1997) . We now provide direct evidence from three different types of neuronal cells, i.e., C6, NB2A, and PC-12 cells, that wild type Rheb is constitutively in a highly activated state, even in serum-starved cells. Thus, compared to its close relatives Ras and Rap 1, Rheb appears to be unique. The degree of Rheb activation in the neuronal cells was similar to what we have found for mutated constitutively-activated Ras proteins, either H-Ras G12V expressed in NIH3T3 cells or N-Ras Q61L, the transforming protein in HL-60 promyelocytic leukemic cells (Scheele et al., 1995; Guha et al., 1996; Pilz et al., 1997) . The basis for the high activation state of Rheb was not, however, from the arginine in position 15, nor the serine in position 16 (corresponding to Ras residues 12 and 13), since mutation of these two residues to glycine had no effect on Rheb's activation level when transfected into CHOK-1 cells. These data are supported by the original finding of Yamagata et al.
(1994) that purified Rheb hydrolyzed [g-32 P]GTP at a rate comparable to that of Ras; this is in marked contrast to Ras with a glycine to valine mutation at position 12 which hydrolyzes GTP at a rate approximately 1/50th that of wild type Ras (Cale´s et al., 1988) . Thus, unlike one would have originally predicted, the data suggest that Rheb's high activation state is not intrinsic to the protein, but rather may be secondary to a relatively high intracellular ratio of activating proteins, i.e., guanine nucleotide exchange factors (GEFs), to inactivating proteins, i.e., GAPs.
Further evidence that there may be relatively more intracellular GEF than GAP activity for Rheb is that increased levels of Rheb expression caused a progressive increase in Rheb activation, with the increased Rheb activation occurring at Rheb protein concentrations that were only several-fold higher than endogenous Rheb. Since we observed the same progressive increase in Rheb activation in both CHOK-1 cells, which do not express endogenous Rheb, and BHK cells, which do express Rheb, the data suggest that Rheb GEF(s) and GAP(s) may be shared with other Ras family members. However, the GAP(s) is/are unlikely to be RasGAP or neurofibromin since neither of these proteins increased the intrinsic GTPase activity of Rheb in vitro (Yamagata et al., 1994) . These data additionally provide a cautionary note to experiments in which Ras-related proteins are over-expressed in cells: at levels only a few-fold higher than that of the endogenous protein, excessively high degrees of activation could occur due to saturation of normal regulatory mechanisms, which could result in non-physiological effects.
Functional analyses of Rheb in S. cerevisiae and S. pombe have revealed that Rheb plays rather diverse roles. In S. cerevisiae, Rheb regulates cellular uptake of arginine and lysine, and this appeared to be a specific Rheb function since no other phenotypic abnormalities were found in Rheb-deficient cells (Urano et al., 2000) . This appears to be the first example of a Ras-related protein regulating amino acid transport. In S. pombe, Rheb inhibits the entry of cells into stationary phase when extracellular nitrogen levels are adequate for cell growth (Mach et al., 2000) ; this is in contrast to Ras which regulates mating in response to limiting nutrients.
Compared to the yeast proteins, the function of mammalian Rheb is less clear. Rheb expression was initially found to be rapidly and transiently induced at the transcriptional level by seizures in hippocampal granule cells, and Rheb was found to be an immediate early gene in PC12 cells and Balb/c 3T3 fibroblasts (Yamagata et al., 1994) . Rheb was subsequently found to bind Raf-1 kinase, and the combination of Rheb and Raf-1 synergistically transformed NIH3T3 fibroblasts as potently as the combination of Ras and Raf-1 (Yee and Worley, 1997) . Another group found, however, that Rheb, like Rap 1A, antagonized Rasinduced transformation of NIH3T3 cells, and proposed that this was most likely through competition for Raf-1 (Clark et al., 1997) . We now report that Rheb binds to B-Raf kinase and inhibits its activity, and that Rheb inhibits downstream functions of B-Raf, i.e., activation of the transcription factor Elk-1 (other workers apparently have found similar results, because in a recent chapter in Methods of Enzymology, the authors cite unpublished data that Rheb inhibits B-Raf kinase (Urano et al., 2001) ). Rheb did not affect Raf-1 activation of the Elk-Gal 4 reporter construct, indicating that Rheb's effect on B-Raf kinase was specific, and not secondary to global inhibition of the reporter system. These latter studies were performed in BHK cells, and the lack of stimulation of Raf-1-dependent transcriptional activation by Rheb may be cell-type specific, similar to Rap 1's stimulation of BRaf kinase (Vossler et al., 1997) .
The inhibition of B-Raf kinase activity and function by Rheb is in stark contrast to Ras and Rap 1, both of which activate B-Raf kinase and increase B-Raf kinase signaling. Thus, although Rheb is a close relative of Ras and Rap 1, and is in the immediate Ras/Rap/Ral family (Reuther and Der, 2000) , Rheb appears to function differently from these two other proteins. Future studies will be aimed at determining the molecular basis for the differences between Rheb and Ras/Rap 1, which could be secondary to amino acid differences in the extended effector domain.
Materials and methods

Cell culture and transfection experiments
BHK, CHOK-1, NB2A, and PC-12 cells were cultured as described previously (Suhasini et al., 1998; Qiu et al., 2000) . For transfection experiments, cells were plated in either 6-or 12-well cluster dishes and 24 h later were transfected with a total of either 1.2 or 0.5 mg of DNA using LipofectAMINE Plus TM or LipofectAMINE 2000 TM (Life Technologies, Inc.) as described previously (Suhasini et al., 1998; Qiu et al., 2000) . The following plasmids were used: pMT2-Rheb (Yee and Worley, 1997), pRK5-myc-Rheb (Yee and Worley, 1997) , pDCR-H-Ras(Val12) (from M Wigler (White et al., 1995) ), pCMV-Rap 1A (from L Quilliam (Quilliam et al., 1990) ), pcDNA3-B-Raf (from P Stork (Vossler et al., 1997) ), pcDNA3-EE-B-Raf (Qiu et al., 2000) , pCMV5-Raf-1 (from H Mischak (Mischak et al., 1996) ), pELK-Gal4 (from G Johnson (Johnson et al., 1996) ), and pCMV-HA-ERK-1 and pGAL4-Luc (both from M Karin (Johnson et al., 1996) ).
Site-directed mutagenesis and DNA sequencing Rheb R15G or R15G/S16G expression constructs were made with a two step polymerase chain reaction (PCR) amplification process using wild type pRK5-myc-Rheb as template. In the first PCR, the SP6 primer was used as the sense primer together with respective mutant primers 5'-GAGGAC-TTTCCCACAGACCCATAGCCCAGGATGGCGATCT-3' and 5'-ATGAGGACTTTCCCACACCACCATAGCCCAG-GATGGCGATCT-3' that were used as antisense. The first PCR products were then used as sense primers and 5'-G GCGCGTCACGCGGCCGCTCACGAAGACTTCCCTT-GTGAAGC-3' (NotI) were used as antisense to amplify the full-length mutant. The amplified products were digested with SalI and NotI, and subcloned into the pRK5-myc expression vector. Clones were analysed by restriction analysis and DNA sequencing.
Western blotting
Western blots were generated as described previously (Scheele et al., 1994) using the following antibodies: two different polyclonal goat anti-Rheb antibodies (anti-Rheb C and antiRheb N, Santa Cruz Biotechnology), a rabbit polyclonal anti-B-Raf kinase antibody (Santa Cruz Biotechnology), and mouse monoclonal anti-myc and anti-EE epitope antibodies (original clones were from the American Type Culture Collection, and G Walter, UCSD, respectively). Briefly, cells were extracted in a sodium dodecyl sulphate (SDS)-based buffer, and proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE). The proteins were transferred to polyvinylidene fluoride membranes which were blocked with 1% milk protein and incubated with the indicated antibodies. After washing, the membranes were incubated with appropriate horseradish peroxidase-complexed secondary antibodies, and proteins were detected by enhanced chemiluminescence.
Measurement of Rheb activation
The activation state of Rheb, i.e., the per cent of Rheb molecules in the active GTP-bound state, was determined both for the endogenous protein, and for myc-tagged Rheb expressed from the pRK5-myc-Rheb vector. Both of these assays are based on well-established methods for measuring Ras activation (Scheele et al., 1995; Dupuy et al., 2001; Prigent et al., 1996; Sharma et al., 1998; Suhasini et al., 1998) .
For endogenous Rheb, cells were rapidly extracted in an ice-cold HEPES-based buffer containing 10 mM MgCl 2 , protease inhibitors, and 1% Nonidet P-40 (Scheele et al., 1995) . The extracts were clarified by a brief centrifugation, and to the supernatants were added protein G agarose and either the anti-Rheb C antibody or goat IgG; all samples received 500 mM NaCl, 0.5% deoxycholate, and 0.05% SDS. After shaking for 1 h at 48C, the agarose beads were washed four times in lysis buffer containing NaCl and detergents, and two times in 20 mM TrisPO 4 , 5 mM Mg 2 SO 4 . The beads were resuspended in 20 mM TrisPO 4 , 1 mM DTT, 1 mM EDTA, and heated at 1008C for 3 min to elute GTP and GDP bound to the immunoprecipitated Rheb. GTP, and the sum of GTP plus GDP, were measured in coupled enzymatic assays. GTP was converted to ATP by nucleoside diphosphate kinase in the presence of excess ADP with the resulting ATP measured by the luciferase method; this assay is sensitive to 1 fmol, and because the second reaction is irreversible due to light generation, both reactions go to completion making the entire system quantitative (Sharma et al., 1998) . The sum of GTP plus GDP was measured by converting GDP to GTP using pyruvate kinase and phosphoenolpyruvate; GTP, which now represents the sum of GDP plus GTP, was measured as just described. We define our lower limits of detection as experimental sample values being twice that of control sample values, and in these studies, experimental samples were generally 10 times higher than the corresponding control samples.
For measuring the activation state of myc-tagged Rheb, CHOK-1 cells were transfected with 15 -150 ng of pRK5-myc-Rheb. Thirty-six hours later cells were harvested and processed as described for measuring endogenous Rheb except the anti-Rheb antibody was replaced by an anti-myc antibody.
Assessment of B-Raf kinase association with Rheb
CHOK-1 and BHK cells were transfected with either myctagged Rheb and non-tagged B-Raf kinase, or with EEtagged B-Raf kinase and non-tagged Rheb, and 36 h later cells were extracted in a HEPES-based buffer containing 1% Nonidet P-40 and protease and phosphatase inhibitors. The extracts were incubated with either an anti-myc antibody or anti-EE antibody, and the immunoprecipitates were collected on agarose beads. After four washes in lysis buffer, the proteins were eluted in SDS sample buffer and separated by SDS -PAGE. Proteins were transferred to membranes, and Western blots were generated as described above using either an anti-B-Raf kinase antibody or an anti-Rheb antibody.
Measurement of B-Raf kinase activity
B-Raf kinase activity was measured as described previously (Suhasini et al., 1998; Qiu et al., 2000) . Briefly, CHOK-1 cells were co-transfected with EE-tagged B-Raf kinase expression vector, and empty vector, Rheb, or Ras expression vectors. The cells were harvested 36 h later and extracted as described for assessing B-Raf kinase association with Rheb. B-Raf kinase was isolated by immunoprecipitation on agarose beads, and the beads were washed three times in lysis buffer, and two times in lysis buffer lacking detergent. The beads were then incubated for 5 -15 min at 378C in 20 ml of reaction buffer containing 50 mM [g-32 PO 4 ]ATP (New England Nuclear), and 300 ng of recombinant catalyticallyinactive MEK-1 (Santa Cruz Biotechnology). The reaction was terminated by adding SDS sample buffer and heating to 1008C for 3 min. The samples were centrifuged and the supernatants were subjected to SDS -PAGE/autoradiography. The assay was linear with time and with the amount of extract protein, and in each assay two timepoints were measured.
Measurement of ERK-1 activation
ERK-1 activity was measured in serum-starved CHOK-1 cells as described previously (Suhasini et al., 1998) . Briefly, cells were transfected with 100 ng of HA-tagged ERK-1 in the absence or presence of 10 ng pcDNA3-B-Raf, and 12.5, 25, or 75 ng of pMT2-Rheb; in some experiments, 25 ng of pDCR-H-Ras(Val12) was substituted for the pMT2-Rheb DNA. The cells were incubated for 40 h post transfection in 0.1% FBS plus 0.1% bovine serum albumin, harvested, and ERK-1 was isolated by immunoprecipitation using an anti-HA antibody (BabCO). After washing the beads, ERK-1 activity was measured by following the phosphorylation of myelin basic protein using ]ATP. The assay was linear with time and extract protein, and the data are expressed as a per cent change in B-Raf kinase-dependent ERK-1 activity.
Reporter gene assays
NB2A, PC-12, BHK, and CHOK-1 cells grown in 12-well cluster dishes were co-transfected with 100 ng of the reporter plasmid pGAL4-Luc, 50 ng of pRSV-bGal (which served as an internal control for transfection efficiency), and 1 -2 ng of pELK-Gal4. As indicated, cells additionally received 10 -50 ng of pcDNA3-B-Raf with or without 5 -100 ng of pMT2-Rheb, 10 -100 ng of pDCR-H-Ras(Val12), or 100 ng of pCMV-Rap 1A; a variable amount of pRC/CMV was included for a total of 500 ng of transfected DNA. In some experiments, pcDNA-B-Raf was replaced by 25 ng of pCMV5-Raf-1. Cells were incubated in low serum-containing medium (0.1% FBS plus 0.1% bovine serum albumin) and harvested 40 h post transfection; the experiments could not be performed in the complete absence of serum because of a high rate of cell death. Luciferase and b-galactosidase activities were measured in cell lysates as described previously (Qiu et al., 2000) in the presence of luciferin and the chemiluminescent substrate Galacton (Tropix, Inc.), respectively.
